Share

SEARCH-Youth: a cluster randomized trial of a multilevel health system intervention to improve virologic suppression in adolescents and young adults living with HIV in rural Kenya and Uganda

Title
Presenter
Authors
Institutions

BACKGROUND: Social and cognitive developmental events disrupt care and medication adherence among adolescents and young adults living with HIV in sub-Saharan Africa. We hypothesized that a dynamic multilevel health system intervention helping adolescents and young adults and their providers navigate life-stage related events would increase virologic suppression compared to standard care.
METHODS: This was a cluster-randomized trial of 28 clinics and youth aged 15'24 years living with HIV in rural Kenya and Uganda. Participants in intervention clinics received life-stage specific assessment and counseling at the start of routine visits, choice of flexible clinic access and rapid viral load feedback. roviders had a secure mobile platform for inter-provider consultation. The primary endpoint was virologic suppression (< 400 copies/ml) two years from enrollment and compared by arm using targeted minimum loss-based estimation, adjusting for clustering by clinic.
RESULTS: Among 1834 participants, median age was 21 years and 82% were female; 85% of intervention participants had life-stage assessments performed '¥ 4 times, 60% opted for phone visits at least once, and >87% of participants in 13/14 clinics received viral load feedback within 72 hours. The proportion of participants with virologic suppression was higher in the intervention arm [88% (95%CI: 85-92%)] than in the control arm [80% (95%CI: 77-84%)], for an adjusted risk ratio of 1.10 (95%CI: 1.03-1.16; p=0.002). The intervention resulted in increased virologic suppression within subgroups of sex, age, and care-status at baseline, with greatest improvement among those re-engaging in care [adjusted risk ratio =1.60 (95% CI:1.00-2.55; p=0.03)] (Figure).
CONCLUSIONS: The multilevel SEARCH-Youth intervention resulted in increased virologic suppression compared to standard care, during a period of transition to dolutegravir and during the COVID19 pandemic. Added to current efforts, systematic life-stage-based assessment and support could help bring adolescents and young adults living with HIV closer towards a goal of universal virologic suppression.